Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

Clin Infect Dis. 2005 Feb 15;40(4):e35-7. doi: 10.1086/427752. Epub 2005 Jan 25.

Abstract

We describe 4 cases of zygomycosis that occurred after prolonged use of voriconazole in severely immunocompromised patients with hematologic disease. An invasive infection was present in 3 patients who died soon after the diagnosis at 12, 13, and 45 days. Physicians should be mindful of this potential risk after treatment with voriconazole.

Publication types

  • Case Reports

MeSH terms

  • Absidia / isolation & purification
  • Adult
  • Antifungal Agents / therapeutic use*
  • Child, Preschool
  • Female
  • Hematologic Diseases / complications*
  • Humans
  • Immunocompromised Host*
  • Male
  • Middle Aged
  • Mucormycosis / drug therapy
  • Mucormycosis / microbiology*
  • Mucormycosis / mortality
  • Mucormycosis / surgery
  • Pyrimidines / therapeutic use*
  • Rhizomucor / isolation & purification
  • Rhizopus / isolation & purification
  • Time Factors
  • Treatment Outcome
  • Triazoles / therapeutic use*
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole